Decoy Therapeutics Inc. (DCOY) Free cash flow 2016–2025
Decoy Therapeutics Inc. (DCOY) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$5.4MFY2025 · since FY2016: -$32.6M → -$5.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.4M | -19.4% |
| FY2024 | -$4.5M | — |
| FY2021 | -$10.2M | +1.1% |
| FY2020 | -$10.3M | +10.9% |
| FY2019 | -$11.6M | -377.2% |
| FY2018 | $4.2M | +115.0% |
| FY2017 | -$27.8M | +14.6% |
| FY2016 | -$32.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More DCOY financial trends
DCOY RevenueDCOY Net incomeDCOY Net marginDCOY Gross profitDCOY Gross marginDCOY Operating incomeDCOY Operating marginDCOY Operating cash flowDCOY Capital expendituresDCOY Return on equityDCOY Stock buybacksDCOY Dividends paidDCOY Total assetsDCOY Total liabilitiesDCOY Shareholders’ equityDCOY overview →